Introduction {#s1}
============

Ectodermal dysplasia syndromes (ED) refer to a group of heterogeneous, inherited disorders characterized by abnormal development of tissues and organs derived from the ectoderm. The incidence is 1 in 100,000 people. There are over a hundred types with variable expression of the effects to the primary and permanent dentitions, skin, sweat glands, hair, nails and other ectodermal structures.^[@R1]^ The majority of the subjects affected by the condition have normal brain development and life expectancy. The two major types of ED syndromes are described as hypohidrotic and hidrotic, depending on sweat gland function. Hypohidrotic ED (HED) is the most common form and is named for the absence of sweat glands. Dry skin, eyes, airways and mucous membranes can occur as a result of impaired development of exocrine glands.^[@R2]^ In addition to the hypohidrosis seen in HED, hypotrichosis and severe hypodontia are usually present.^[@R3]^

ED can be inherited by multiple Mendelian pathways: X-linked recessive, autosomal dominant, autosomal recessive, or *de novo*.^[@R4]^ Although there are multiple patterns of inheritance, the genetic mutation most commonly occurs in the *EDA* (Ectodysplasin A) gene complex ([Figure 1](#F1){ref-type="fig"}).^[@R5]^
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Recombinant EDA replacement therapy was successful in dogs and is a promising approach to correct the consequences of inactivating mutations of ectodysplasin A (*EDA*) that lead to X-linked ectodermal dysplasia (ED) in humans.^[@R6]^ Identification of potential subjects for a future human trial is an important component of the planning phase of future studies.

The aim of this research hypothesis was to test two 8-year-old identical twin sisters with ED and their unaffected parents for the presence of mutations in the*EDA* gene with the hypothesis that they might be carrying a *de novo* mutation in *EDA* and potentially eligible for recombinant EDA therapy. A complete understanding of the etiology of their ED would be used in conjunction with clinical and environmental features to make appropriate treatment recommendations.

Case report {#s2}
===========

Identical 8-year-old twin girls were referred by a private dentist in Johnstown, PA, to the University of Pittsburgh School of Dental Medicine (SDM), Department of Pediatric Dentistry ([Figure 2](#F2){ref-type="fig"}). Detailed extraoral and intraoral clinical presentation features were recorded for the twin patients, their parents and one grandparent. The children were confirmed to have ectodermal dysplasia primarily affecting their teeth. There were no other obvious features of ectodermal dysplasia such as sparse hair, dry skin, dysplastic nails, or reports of lack of sweating or fevers when temperature is high. The unaffected mother had agenesis of three third molars (both maxillary and left mandibular) and no other relevant findings. The father was unaffected with an intact dentition. They have a younger brother. The paternal grandmother had agenesis of the left mandibular lateral incisor and the paternal grandfather had no history of tooth agenesis. No information could be obtained for the maternal grandparents.
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The subjects and their parents were part of the University of Pittsburgh School of Dental Medicine Dental Registry and DNA Repository project, which is approved by the University of Pittsburgh Institutional Review Board (University of Pittsburgh IRB approval 0609091). Informed consent was obtained from the parents and appropriate assent was obtained from the patients to provide a saliva sample without the use of saliva stimulatory tools. DNA was isolated from the saliva samples collected from the twin children and their parents in Oragene kits (DNA Genotek, ON, Canada) according to the manufacturer\'s instructions. Primers for the Ectodyplasin (*EDA*), Ectodysplasin Receptor (*EDAR*), Ectodysplasin Receptor Associated Death Domain (*EDARADD*), and Connexin-30 (*GJB6*) genes were obtained from the literature.^[@R7]-[@R10]^ The primers used are listed in [Table 1](#T1){ref-type="table"}.

###### Primers and PCR conditions used in this study

  ----------------- ------------------------------ ------------------------------ ------------------------------------- ----------------------
  **Gene**          **Primer Sequence, Forward**   **Primer Sequence, Reverse**   **Annealing Temperature (Celsius)**   **Size of Fragment**
  EDA.Exon 4        CCGAGATCGTGCCACTGAACT          CCC CAT CTC CAC CGT TTG AA     53                                    368
  EDA.Exon 1-1      AGAGGTCGTGAACGGCTGAGG          CGCAACTCTAGGTAGCAGCACAAC       54                                    264
  EDA.Exon1--2      GCCTGCTCTTCCTGGGTTTCTT         TCCCTGGTCCTGCCCTCTAAAT         54                                    400
  EDA.Exon2         GCTGGTTTTTTATGTTGGCTATGAC      CCACCATGCCCTACCAAGAAG          52                                    266
  EDA.Exon3         TTTGCAGTGTCTTGGGGATCC          GCAGGGAGAAGAACAAGGAAGAAT       53                                    346
  EDA.Exon5         TCAGGTGAGGGGAAAAGGAAGT         GGGCTGTGAGTGAAAACCGTC          52                                    240
  EDA.Exon6         AGGGGAGAGGGATCAGAATTG          AGGCTGGGTGATTATTTGGAG          50                                    256
  EDA.Exon7         TGCCTCGATTATTCTGACATGTACTG     CCCAAAGCAGGAAGTTAGCCATT        53                                    300
  EDA.Exon8         CCCCACCCTCTCTTTCCTCTCTTC       GGCTGCAACACCAATACACCTCAC       56                                    412
  EDAR.Exon2        TTTGCTGGAAGGCACCTTAT           AGAGGCCAAGAAACAGTCCA           58--62                                243
  EDAR.Exon3        ACCCCCTTCCTATGTCAACC           CAGGCTCAGGGCAACAAT             56--62                                292
  EDAR.Exon4        CGGCAAGAGTAGCTTCTGGA           GCAGTATCCATGACCCCTGT           51--63                                397
  EDAR.Exon5        GTGCTCTCTGCACCAGTCC            GACCGGCTCTTTCCTACACC           52--63                                246
  EDAR.Exon6        AGCTCTGTGGCAGCGTCT             CCTCTCCTCTTCTGAGCTTTCA         51--62                                228
  EDAR.Exon7/8      GGAGTCCTGGAGGGAAGACC           AGCATGTGAGAGCAGAAGCA           60                                    468
  EDAR.Exon9        AGAGCAGGGTTGGGCTGAG            GCTAGCCTGTCAGTTCACTCG          51--63                                248
  EDAR.Exon10       AGGTGCCCAGTAAACACCTG           CGTCTTGCAGGAGAGCTGAT           51--63                                400
  EDAR.Exon11       CCTGCTGACATGGAGGATTT           CTCAGTTCCCCTCACAGGAG           51--63                                234
  EDAR.Exon 12      GACCTTCTATTGACTGTGACTTGC       CAGTCTTTTGGCACCACTCA           51-63                                 461
  EDARADD.Exon1-1   GAAAGAACCACAAACCAAACC          TGCCTTCAC ACATAAGAACAG         53-54                                 452
  EDARADD.Exon1-2   AGGTACCGAGGGACGCGC             GGCCTCGATAGCCCTGCG             61-63                                 323
  EDARADD.Exon2     GATTACAGCATGAGCTACCTC          CCAGGGAAGTGGGTAAAGCC           53-58                                 516
  EDARADD.Exon3     CCTTGATTTCATTCCTGTCGA          GTCACGAGCTAATCTATGGGCATG       53-58                                 352
  EDARADD.Exon4     ATCCTTAAGAGCAGAGTTTGG          CTGTTTATGATCTAG AAATCCTG       49-52                                 348
  EDARADD.Exon5     GCGCTCAAGGTGCTCGTATTC          TTACAGGCGCCCACCACAACC          59-63                                 463
  EDARADD.Exon6-2   CGTGTCACCCAACGGTGAAAA          CCTCCACAA AACTGCCAG C          57-58                                 405
  EDARADD.Exon6-1   AAAGAAAGAAACGAGCATTCT          CTGTTCCGGAGCAAGAACTC           50-56                                 387
  Cx30              AGCAGGGCAGGGAGT TGAAG          TCAGGTTGGTATTGCCTTCTGG         57                                    1008
  Cx30.3            CAATCGCACCAGCATTAAGGG          TGATCTTATCTGCTGATCTCGCAG       57                                    952
  ----------------- ------------------------------ ------------------------------ ------------------------------------- ----------------------

Polymerase chain reaction (PCR) conditions were optimized for the primers using stock DNA and a standard PCR protocol. The standard PCR protocol consisted of an initial denaturation step at 95°C for 30 seconds, followed by 30 cycles of denaturation at 94°C for 45 seconds, with a final extension step at 72°C for 5 minutes. PCR product amplification was confirmed by a 3% ethidium bromide agarose gel.

PCR products were cleaned using the PEG precipitation of PCR product protocol. The samples were prepared for sequencing by the Sanger sequencing method used at the Genomics and Proteomics Core facility at the University of Pittsburgh. Microsequencing was completed by capillary electrophoresis using either an Applied Biosystems 3130 or 3730 XL DNA analyzer. The Applied Biosystems sequence software was used for lane tracking and first pass base calling. The sequences were analyzed for mutations by comparing the obtained sequence with a reference gene sequence. Sequencing results were also studied in relation to the clinical presentations of the twin patients and their parents.

Exons and introns from *EDA*, *EDAR*, *EDARADD* and *GJB6* were sequenced for both parents and the affected daughters. No mutations were detected in *EDA* or *GJB6*. Genetic variants located in the intron of *EDAR* were found but determined to be non-contributory to the twins' ED. A microsatellite polymorphism was detected in all four subjects in exon 4 of the *EDARADD* gene but determined not to be causal to the ED. There was a silent mutation detected in exon 6 of the *EDARADD* gene of both daughters and their mother. This mutation was not found in the father and was unlikely to be the cause of the ED. The base pair T replaced a C but translated to the same amino acid, aspartic acid. This silent mutation has already been reported in the literature and is unlikely to be responsible for ectodermal dysplasia.

Discussion {#s3}
==========

Based on clinical presentations, as well as the genetic analysis of the twin girls and their parents, an X-linked recessive pattern of inheritance can be ruled out as a mode of inheritance. There were no mutations found in the *EDA* exons commonly associated with X-linked recessive inheritance. These data confirm that the inheritance pattern is most likely not X-linked recessive.

There were no mutations found in the *EDAR*, nor were *EDARADD* exons reported in conjunction with autosomal dominant and recessive forms of ED. No mutations were detected in *EDA* or *GJB6*. These findings cannot confirm an autosomal dominant or recessive transmission either. According to this initial genetic analysis, the ED mutation is probably located on another gene not examined in this family. An autosomal dominant, or recessive, *de novo* genetic mutation may be located in another pathway involved in ectodermal development in genes such as *MSX1*^[@R11]^ or members of the WNT family.^[@R12]^ It is likely that the ED of these subjects is caused by a *de novo* mutation in a gene not studied yet. Clinically, the case presented here has the primary features of an ectodermal dysplasia affecting teeth and is comparable to previous reports that identified mutations in *EDA*, *EDAR*, *EDARADD* or *GJB6*.^[@R7]‒[@R10]^ Aside from the challenges of rehabilitating extensive areas of the arches with congenitally missing teeth, the lifetime prognosis of the condition in the affected children is unlikely to be different from any other similar cases.^[@R5]^

Additionally, analysis of these genes and others is necessary to confirm the etiology of ED in the twin\'s patients. Further research in this area would include sequencing genes outside of the EDA complex less commonly associated with ectodermal dysplasia syndromes. These genes would include *MSX1* or genes in the WNT pathway.

Conclusion {#s4}
==========

1.  Four different genes commonly associated with ED were eliminated as the location of the disease-causing mutation. These results suggest that the ED of the subjects is caused by a *de novo* mutation in a gene not studied here. Aside from defining the ectodermal dysplasia of these patients as primarily affecting the teeth, we are not able to be more precise.

2.  It is likely that these subjects and their future offspring would not benefit from the development of recombinant EDA replacement therapy.

3.  When the precise sporadic mutation is confirmed, patients with ED can be provided with a diagnostic target for prenatal management. In confirming the genetic etiology, the patients and their parents may more readily accept the situation in knowing the cause. This acceptance may help them better live with the disorder.
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